1. Home
  2. DMRA vs BLKB Comparison

DMRA vs BLKB Comparison

Compare DMRA & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Damora Therapeutics Inc. Common Stock

DMRA

Damora Therapeutics Inc. Common Stock

SELL

Current Price

$22.10

Market Cap

1.4B

Sector

Health Care

ML Signal

SELL

Logo Blackbaud Inc.

BLKB

Blackbaud Inc.

SELL

Current Price

$52.51

Market Cap

1.5B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
DMRA
BLKB
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
DMRA
BLKB
Price
$22.10
$52.51
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$46.78
★ $56.25
AVG Volume (30 Days)
★ 478.7K
389.9K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
121.48
★ 142.32
EPS
N/A
★ 2.49
Revenue
N/A
N/A
Revenue This Year
N/A
$4.30
Revenue Next Year
N/A
$4.68
P/E Ratio
★ N/A
$21.66
Revenue Growth
N/A
N/A
52 Week Low
$16.50
$25.58
52 Week High
$34.89
$64.84

Technical Indicators

Market Signals
Indicator
DMRA
BLKB
Relative Strength Index (RSI) 49.17 49.67
Support Level $18.03 $45.71
Resistance Level $22.27 $53.25
Average True Range (ATR) 1.83 1.70
MACD 0.03 -0.54
Stochastic Oscillator 30.13 17.31

Price Performance

Historical Comparison
DMRA
BLKB

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

Share on Social Networks: